Keryx Biopharmaceuticals, Inc. (KERX) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts KERX Hot Sheet
Price: $3.36 --0%
Financial Fact:
Total research and development: 8.67M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total research and development: 8.67M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) reported Q4 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14).
For earnings history and earnings-related data on Keryx Biopharmaceuticals, Inc. (KERX) click here.
For earnings history and earnings-related data on Keryx Biopharmaceuticals, Inc. (KERX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- CoStar Group acquires Zonda for $800M, adding new home data
- UBS says bull market has further to run
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
